Chimerix Company Profile
What is the competitive landscape for CHIMERIX
CHIMERIX has one approved drug.
There are seven US patents protecting CHIMERIX drugs.
Drugs and US Patents for Chimerix
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chimerix | MODEYSO | dordaviprone hydrochloride | CAPSULE;ORAL | 219876-001 | Aug 6, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Chimerix | MODEYSO | dordaviprone hydrochloride | CAPSULE;ORAL | 219876-001 | Aug 6, 2025 | RX | Yes | Yes | 10,172,862 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chimerix | MODEYSO | dordaviprone hydrochloride | CAPSULE;ORAL | 219876-001 | Aug 6, 2025 | RX | Yes | Yes | 9,265,765 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Chimerix | MODEYSO | dordaviprone hydrochloride | CAPSULE;ORAL | 219876-001 | Aug 6, 2025 | RX | Yes | Yes | 10,369,154 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Chimerix Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Cyprus | 1121628 | ⤷ Start Trial |
| Canada | 3204801 | ⤷ Start Trial |
| Hungary | E056389 | ⤷ Start Trial |
| Denmark | 3805222 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

